vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and DNOW Inc. (DNOW). Click either name above to swap in a different company.

DNOW Inc. is the larger business by last-quarter revenue ($959.0M vs $749.2M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — 3.6% vs -16.8%, a 20.4% gap on every dollar of revenue. On growth, DNOW Inc. posted the faster year-over-year revenue change (68.0% vs 62.0%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 30.5%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

DNOW Inc., operating under the trade name DistributionNOW, is a global industrial and energy products distributor. It provides supply chain management, inventory optimization, and technical support services, offering parts, equipment, and consumables for oil and gas, renewable energy, manufacturing, and construction sectors, with operations spanning North America, Europe, and Asia-Pacific.

CLOV vs DNOW — Head-to-Head

Bigger by revenue
DNOW
DNOW
1.3× larger
DNOW
$959.0M
$749.2M
CLOV
Growing faster (revenue YoY)
DNOW
DNOW
+5.9% gap
DNOW
68.0%
62.0%
CLOV
Higher net margin
CLOV
CLOV
20.4% more per $
CLOV
3.6%
-16.8%
DNOW
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
30.5%
DNOW

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
DNOW
DNOW
Revenue
$749.2M
$959.0M
Net Profit
$27.3M
$-161.0M
Gross Margin
5.2%
Operating Margin
3.6%
-19.6%
Net Margin
3.6%
-16.8%
Revenue YoY
62.0%
68.0%
Net Profit YoY
-905.0%
EPS (diluted)
$0.05
$-1.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
DNOW
DNOW
Q1 26
$749.2M
Q4 25
$487.7M
$959.0M
Q3 25
$496.6M
$634.0M
Q2 25
$477.6M
$628.0M
Q1 25
$462.3M
$599.0M
Q4 24
$337.0M
$571.0M
Q3 24
$331.0M
$606.0M
Q2 24
$356.3M
$633.0M
Net Profit
CLOV
CLOV
DNOW
DNOW
Q1 26
$27.3M
Q4 25
$-49.3M
$-161.0M
Q3 25
$-24.4M
$25.0M
Q2 25
$-10.6M
$25.0M
Q1 25
$-1.3M
$22.0M
Q4 24
$-22.1M
$20.0M
Q3 24
$-9.2M
$13.0M
Q2 24
$7.4M
$24.0M
Gross Margin
CLOV
CLOV
DNOW
DNOW
Q1 26
Q4 25
5.2%
Q3 25
22.9%
Q2 25
22.9%
Q1 25
23.2%
Q4 24
22.6%
Q3 24
24.5%
22.3%
Q2 24
30.3%
21.8%
Operating Margin
CLOV
CLOV
DNOW
DNOW
Q1 26
3.6%
Q4 25
-10.1%
-19.6%
Q3 25
-4.9%
5.2%
Q2 25
-2.2%
5.1%
Q1 25
-0.3%
5.0%
Q4 24
-6.4%
4.4%
Q3 24
-2.7%
3.8%
Q2 24
2.0%
5.2%
Net Margin
CLOV
CLOV
DNOW
DNOW
Q1 26
3.6%
Q4 25
-10.1%
-16.8%
Q3 25
-4.9%
3.9%
Q2 25
-2.2%
4.0%
Q1 25
-0.3%
3.7%
Q4 24
-6.6%
3.5%
Q3 24
-2.8%
2.1%
Q2 24
2.1%
3.8%
EPS (diluted)
CLOV
CLOV
DNOW
DNOW
Q1 26
$0.05
Q4 25
$-1.42
Q3 25
$0.23
Q2 25
$0.23
Q1 25
$0.20
Q4 24
$0.19
Q3 24
$0.12
Q2 24
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
DNOW
DNOW
Cash + ST InvestmentsLiquidity on hand
$177.6M
$164.0M
Total DebtLower is stronger
$411.0M
Stockholders' EquityBook value
$339.4M
$2.2B
Total Assets
$697.7M
$3.9B
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
DNOW
DNOW
Q1 26
$177.6M
Q4 25
$78.3M
$164.0M
Q3 25
$266.0M
Q2 25
$232.0M
Q1 25
$219.0M
Q4 24
$194.5M
$256.0M
Q3 24
$288.0M
$261.0M
Q2 24
$254.8M
$197.0M
Total Debt
CLOV
CLOV
DNOW
DNOW
Q1 26
Q4 25
$411.0M
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Stockholders' Equity
CLOV
CLOV
DNOW
DNOW
Q1 26
$339.4M
Q4 25
$308.7M
$2.2B
Q3 25
$340.9M
$1.2B
Q2 25
$344.2M
$1.2B
Q1 25
$336.1M
$1.1B
Q4 24
$341.1M
$1.1B
Q3 24
$342.2M
$1.1B
Q2 24
$324.9M
$1.1B
Total Assets
CLOV
CLOV
DNOW
DNOW
Q1 26
$697.7M
Q4 25
$541.0M
$3.9B
Q3 25
$559.7M
$1.7B
Q2 25
$575.0M
$1.7B
Q1 25
$583.7M
$1.7B
Q4 24
$580.7M
$1.6B
Q3 24
$653.0M
$1.6B
Q2 24
$674.2M
$1.6B
Debt / Equity
CLOV
CLOV
DNOW
DNOW
Q1 26
Q4 25
0.18×
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
DNOW
DNOW
Operating Cash FlowLast quarter
$83.0M
Free Cash FlowOCF − Capex
$76.0M
FCF MarginFCF / Revenue
7.9%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$134.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
DNOW
DNOW
Q1 26
Q4 25
$-66.9M
$83.0M
Q3 25
$12.1M
$43.0M
Q2 25
$5.4M
$45.0M
Q1 25
$-16.3M
$-16.0M
Q4 24
$34.8M
$122.0M
Q3 24
$50.0M
$74.0M
Q2 24
$44.8M
$21.0M
Free Cash Flow
CLOV
CLOV
DNOW
DNOW
Q1 26
Q4 25
$-69.0M
$76.0M
Q3 25
$11.4M
$39.0M
Q2 25
$4.8M
$41.0M
Q1 25
$-16.5M
$-22.0M
Q4 24
$33.3M
$119.0M
Q3 24
$49.6M
$72.0M
Q2 24
$44.4M
$18.0M
FCF Margin
CLOV
CLOV
DNOW
DNOW
Q1 26
Q4 25
-14.1%
7.9%
Q3 25
2.3%
6.2%
Q2 25
1.0%
6.5%
Q1 25
-3.6%
-3.7%
Q4 24
9.9%
20.8%
Q3 24
15.0%
11.9%
Q2 24
12.5%
2.8%
Capex Intensity
CLOV
CLOV
DNOW
DNOW
Q1 26
Q4 25
0.4%
0.7%
Q3 25
0.1%
0.6%
Q2 25
0.1%
0.6%
Q1 25
0.0%
1.0%
Q4 24
0.5%
0.5%
Q3 24
0.1%
0.3%
Q2 24
0.1%
0.5%
Cash Conversion
CLOV
CLOV
DNOW
DNOW
Q1 26
Q4 25
Q3 25
1.72×
Q2 25
1.80×
Q1 25
-0.73×
Q4 24
6.10×
Q3 24
5.69×
Q2 24
6.04×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

DNOW
DNOW

Pipelines$455.0M47%
Downstream And Industrial$196.0M20%
Gas Utilities$183.0M19%
Oil And Gas Properties$105.0M11%
Other$20.0M2%

Related Comparisons